Get complete Patent Opposition Report for Medac Gesellschaft Fur Klinische Spezialpraparate

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore patent oppositions filed by Medac Gesellschaft Fur Klinische Spezialpraparate against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP2478907Methods And Compositions For Treating CancerCOUGAR BIOTECHNOLOGYJan 11, 2022
EP2493466Novel Antitumoral Use Of CabazitaxelAVENTIS PHARMAMar 22, 2021
EP3294285Cabazitaxel And Its Use For Treating CancerAVENTIS PHARMASep 18, 2020